Treatment of Gaucher's disease with OGT 918.
Mistry
P K
PK
D017485:1-Deoxynojirimycin / Q000009:adverse effects* / Q000031:analogs & derivatives / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D005776:Gaucher Disease / Q000188:drug therapy* / Q000378:metabolism; D005962:Glucosylceramidase / Q000627:therapeutic use; D005963:Glucosylceramides / Q000378:metabolism; D065089:Glycoside Hydrolase Inhibitors; D006529:Hepatomegaly / Q000188:drug therapy / Q000209:etiology; D006596:Hexosaminidases / Q000097:blood; D006801:Humans; D013163:Splenomegaly / Q000188:drug therapy / Q000209:etiology; D013995:Time
D004791:Enzyme Inhibitors; D005963:Glucosylceramides; D065089:Glycoside Hydrolase Inhibitors; D017485:1-Deoxynojirimycin; C059896:miglustat; D006596:Hexosaminidases; C086400:chitotriosidase; D005962:Glucosylceramidase